Mid-Day Market Update: Crude Oil Rises 1%; REV Group Shares Plummet
Midway through trading Wednesday, the Dow traded down 0.45% to 34,942.88 while the NASDAQ fell 1.09% to 15,207.45. The S&P also fell, dropping 0.55% to 4,495.35.
30 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion all-cash deal.
Mid-Morning Market Update: Markets Mixed; Korn Ferry Reports Upbeat Q1 Results
Following the market opening Wednesday, the Dow traded up 0.03% to 35,111.48 while the NASDAQ fell 0.27% to 15,332.05. The S&P also fell, dropping 0.02% to 4,519.29.
The Daily Biotech Pulse: MacroGenics’ Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA’s FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 7)
21 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Kadmon Holdings, Inc. (NASDAQ: KDMN) rose 75.7% to $9.31 in pre-market trading after France's Sanofi announced plans to buy the company in a $1.9 billion deal.
Sanofi’s $1.9 Billion Bet On Kadmon: What You Need to Know
Underlining the focus on inorganic growth, French pharma giant Sanofi (NASDAQ: SNY) announced a big-ticket acquisition just a month after another
Sanofi to Acquire Kadmon for $9.50/Share in Cash
Sanofi (NYSE: SNY) has entered into a definitive merger agreement with Kadmon Holdings, Inc. (NASDAQ: KDMN).
Wall Street Crime And Punishment: Martha Stewart’s Perfectly Ridiculous Stock Scandal
Does crime pay?
Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition and greed take them in the wrong direction.